Document Detail


Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
MedLine Citation:
PMID:  23057658     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: The development of treatment strategies for cognitive impairment in multiple sclerosis (MS) is still in its infancy. The objective of this prospective, non-randomized, pilot study was to assess the possible efficacy of treatment with natalizumab in comparison with interferon beta (IFNB) in a group of relapsing-remitting (RR) patients with MS. METHODS: We included 12 patients treated with natalizumab and 14 with IFNB. At baseline and at follow-up, cognitive functioning was assessed through the Rao's Brief Repeatable Battery. All the patients underwent brain MR study with the assessment of T2 lesion volumes (T2LV), neocortical volume (NCV), normalized brain volume (NBV) and percentage brain volume change (PBVC). Evolution of cognitive performance was assessed using available normative data for the Italian population. Treatment comparisons were assessed through the Mann-Whitney U-test, anova for repeated measures and linear multivariate regression analyses. RESULTS: After a mean follow-up of 1.5 years, the mean number of neuropsychological tests with a deteriorating performance was significantly lower in patients treated with natalizumab (0.7 ± 0.7 vs. 1.7 ± 1.4; P = 0.031). Likewise, PBVC was significantly lower in natalizumab-treated subjects than that observed in patients treated with IFNB (-0.51 ± 0.47% vs. -1.18 ± 0.98%; P = 0.050). CONCLUION: Our results suggest a potential beneficial effect of natalizumab therapy on cognitive functioning in MS, possibly mediated by a reduction of brain atrophy.
Authors:
E Portaccio; M L Stromillo; B Goretti; B Hakiki; A Giorgio; F Rossi; A De Leucio; N De Stefano; M P Amato
Related Documents :
3480098 - Long-term evaluation of 211 patients with internal derangement of the temporomandibular...
17418708 - Dentoskeletal and soft-tissue changes with cervical headgear and mandibular protraction...
20537778 - Pharyngeal airway changes after sagittal split ramus osteotomy of the mandible: a compa...
918178 - Vertical ramisection for prognathism.
24834758 - Outcome differences in patients with precursor b cell acute lymphocytic leukemia over t...
21327438 - Effect of resveratrol on cartilage protection and apoptosis inhibition in experimental ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-11
Journal Detail:
Title:  European journal of neurology : the official journal of the European Federation of Neurological Societies     Volume:  -     ISSN:  1468-1331     ISO Abbreviation:  Eur. J. Neurol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9506311     Medline TA:  Eur J Neurol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.
Affiliation:
Department of Neurology, University of Florence, Florence, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multiple Intradermal Small Bolus Injection of Botulinum Toxin: the Limit and the Potentiality.
Next Document:  No long-term influence of movement restriction regulations on the contact-structure between and with...